Intellia Therapeutics NTLA Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Intellia Therapeutics's operating margin?
- Intellia Therapeutics (NTLA) reported operating margin of -636.6% in Q1 2026.
- How has Intellia Therapeutics's operating margin changed year-over-year?
- Intellia Therapeutics's operating margin increased by 46.4% year-over-year, from -1,187.4% to -636.6%.
- What is the long-term trend for Intellia Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Intellia Therapeutics's operating margin has grown at a 22.6% compound annual growth rate (CAGR), from -235.5% to -651.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.